US Thyroid Cancer Market: Trends and Opportunities (2015-2019) April 2015
US Thyroid Cancer Market Report Scope of the Report The report titled “U.S Thyroid Cancer Market: Trends & Opportunities (2015 Edition)” analyzes the United States Thyroid Cancer Market, with exhaustive discussion on Thyroid Cancer Diagnostic Surgeries, FNA, Thyroid Cancer Secondary Surgery, Thyroid Cancer Hormone Replacement and Thyroid Cancer Histopathology Market. The key market challenges recognized by the analysts and the major trends in thyroid cancer market are presented in the report. Further, key manufacturers of thyroid cancer market like Veracyte Inc., Mylan Inc., Forest Laboratories, Abott Laboratories and Oxigene Inc. are profiled in the report. Product Coverage • • • • •
Thyroid Cancer Diagnostic Surgeries Thyroid Cancer Histopathology Market Thyroid Cancer Secondary Surgery Thyroid Cancer Hormone Replacement FNA biopsies
Company Coverage • • • • •
Veracyte Inc. Mylan Inc. Forest Laboratories Abott Laboratories Oxigene Inc.
Executive Summary Thyroid cancer, a type of malignant cancer, initiate from follicular and par follicular thyroid cells. The most effective treatment of thyroid cancer is surgical removal of thyroid gland followed by radioactive ablation and thyroid stimulating hormone (TSH) suppression therapy. Chemotherapy is also used in cases of metastasis and progressive stage of thyroid cancer. Thyroid cancer market is accelerating in the United States since 2010 and it is a disease which is fast on the rise. Incidence has more than doubled since the early 1970s, and for women, it is the cancer with the fastest-growing number of new cases. On the back of high incidence of thyroid cancer, it is anticipated that the thyroid cancer market in US will observe impressive double digit growth in next five years. The thyroid cancer diagnosis market is segmented into diagnostic surgeries, histopathology, secondary surgery and annual new patient hormone replacement therapy. The diagnostic technology has improved since 2011 and with use of Afirma GEC test and Afirma FNA; the detection of even minor nodules has become possible. The report titled “US Thyroid Cancer Market: Trends and Opportunities
(2015-2019)� provides an insight into the
overall thyroid cancer market of the United States of America. The report analyzes in detail the segments of Thyroid Cancer Market that includes Thyroid Cancer Diagnostics Surgeries, Thyroid Histopathology Market, Thyroid Cancer Secondary Surgery and Thyroid Cancer Hormone Replacement Market. The report assesses thyroid cancer types, stages and incidence rate of the disease and also discusses the factors that will result in the demand and growth of the market. Further, companies like Veracyte Inc., Mylan Inc., Forest Laboratories, Abott Laboratories and Oxigene Inc. are profiled in the report.
US Thyroid Cancer Market Report It is expected that the thyroid cancer market in U.S will observe impressive double digit growth at CAGR of …..%. The market is expected to reach US$.... billion in 2015 from U.S$.... billion in 2014. Growing at CAGR of ….% the thyroid cancer market is expected to reach US$.... billion in 2019. It is estimated that by 2019 the thyroid cancer market will boom to US$.... billion enhancing the opportunity for new drug entrants.
U.S Thyroid Cancer Market Size; 2010-2014 (US$ Billion)
1000
U.S Thyroid Cancer Market Forecast: 2015-2019 (US$ Billion)
1200
900
1000
800 700
800
600 600
500 400
400
300 200
200 100
0 2015
0 2010
2011
2012
2013
2016
2017
2018
2019
2014
• The market has grown at CAGR of ….% in past five years and is expected to rise further due to increasing number of cancer incidence. The thyroid cancer market in 2011 was US$.... million which increased by ….% and reached US$..... million in 2012.
US Thyroid Cancer Market Report In the United States, papillary thyroid cancer is the most common type. About x of every 100 people with thyroid cancer have this type. If diagnosed early, most people with papillary thyroid cancer can be cured. ….% of incidence in 2013 was of papillary carcinoma, …% of incidence in 2013 was of follicular carcinoma, …% of incidence in 2013 was of medullary carcinoma and anaplastic carcinoma.
US thyroid cancer market in percentage: By Cancer Type
Chart Title
Chart Title Papillary carcinoma Horthle cell carcinoma Anaplastic carcinoma Thyroid sarcoma
U.S thyroid cancer market in percentage : Cases by Cancer Stage
Follicular carcinoma Medullary thyroid carcinoma Thyroid lymphoma
Localized Regional Distant Unknown
Of the entire thyroid cancer incidence found in U.S ….% of the cases are localized and easy to treat or perform surgery. In as many as …% of cases, there are multifocal sites of adenocarcinomas throughout the gland .However, …% of the thyroid cancer incidence is regionally located in the gland and only …% of the nodules are able to spread distantly or unknown which accounts for …%. The lungs and bone are the most frequent distant sites of spread, though such distant spread is rare in this type of thyroid cancer.
Table of Contents: US Thyroid Cancer Market 1. Executive Summary 2. U.S Thyroid Cancer Market: An Introduction 2.1 Cancer Cells 2.2 Types of Thyroid Cancer 2.3 Diagnosis 2.4 Staging 2.5 Treatment 2.5.1 Surgery 2.5.2 Radioactive Iodine Therapy 2.5.3 External Radiation Therapy 2.6 Thyroid Cancer Drugs 3. U.S Thyroid Cancer Market: Sizing and Growth 3.1 U.S Thyroid Cancer Market: 2010-2014 3.2 U.S Thyroid Cancer Market: 2015-2019 4. U.S Thyroid Cancer Market Segmentation 4.1 U.S Thyroid Cancer Diagnostic Surgeries Market 4.1.1 U.S Thyroid Cancer Diagnostic Surgeries Market: 2010-2014 4.1.2 U.S Thyroid Cancer Diagnostic Surgeries Market: 2015-2019 4.2 US Thyroid Cancer Histopathology Market 4.2.1 Thyroid Cancer Histopathology Market: 2010-2014 4.2.2 Thyroid Cancer Histopathology Market: 2015-2019 4.3 US Thyroid Cancer Secondary Surgery Market 4.3.1 U.S Thyroid Cancer Secondary Surgery Market: 2010-2014 4.3.2 U.S Thyroid Cancer Secondary Surgery Market: 2015-2019
Table of Contents: US Thyroid Cancer Market 4.4 US Thyroid Cancer Hormone Replacement Market 4.4.1 U.S Thyroid Cancer Hormone Replacement Market: 2010-2014 4.4.2 U.S Thyroid Cancer Hormone Replacement Market: 2015-2019 4.5 U.S thyroid cancer market: By Cancer Type 4.6 U.S thyroid cancer market: Cases by Cancer Stage 5. U.S Thyroid Cancer Diagnosis Market: By FNA volume 5.1 U.S Thyroid Cancer Diagnosis Market- FNA Volume: 2010-2014 5.2 U.S Thyroid Cancer Diagnosis Market- FNA Volume: 2015-2019 6. Market Dynamics: U.S Thyroid Cancer Diagnosis Market 6.1 Growth Drivers 6.1.1 Fast growing cancer market in the US 4.1.2 Growing Middle Age population 4.1.3 Escalating Healthcare Expenditure in the US 4.1.4 Economic Growth 6.2 Challenges 6.2.1 Risk of surgery 6.2.2 Regulatory issues 6.3 Trends 6.3.1 Rate of survival after diagnosis 4.3.2 Provides cost savings to healthcare suppliers and patients 6.3.3 Early approval of Lenvima presents additional growth opportunities 6.3.4 Launch of Affirma test and GEC 6.3.5 Thyroid Nodules More Common in Women
Table of Contents: U.S Thyroid Cancer Market 7. Competitive Landscape: US Thyroid Cancer Diagnosis Market 8. Company Profiles: US Thyroid Cancer Diagnosis Market 8.1 Veracyte Inc. 8.1.1 Business Overview 8.1.2 Financial Overview 8.1.3 Business strategies 8.2 Oxigene Inc. 8.2.1 Business Overview 8.2.2 Financial Overview 8.2.3 Business strategies 8.3 Forest Laboratories 8.3.1 Business Overview 8.3.2 Financial Overview 8.3.3 Business strategies 8.4 Mylan Inc. 8.4.1 Business Overview 8.4.2 Financial overview 8.4.3 Business strategies 8.5 Abbott Laboratories 8.5.1 Business Overview 8.5.2 Financial Overview 8.5.3 Business Strategy
Figures & Tables: US Thyroid Cancer Market Figure 1: U.S Thyroid Cancer Market-US$ Billion: 2010-2014 Figure 2: U.S Thyroid Cancer Market Segmentation: 2014 Figure 3: U.S Thyroid Cancer Market-US$ Billion: 2015-2019 Figure 4: U.S Thyroid Cancer Diagnostic surgeries: 2010-2014- U.S$ Million Figure 5: U.S Thyroid Cancer Diagnostic surgeries: 2015-2019- U.S$ Billion Figure 6: U.S Thyroid Cancer Histopathology Market:2010-2014-U.S$ Million Figure 7: U.S Thyroid Cancer Histopathology Market:2015-2019-U.S$ Million Figure 8: U.S Thyroid Cancer Secondary Surgery Market:2010-2014-U.S$ Million Figure 9: U.S Thyroid Cancer Secondary Surgery Market: 2015-2019-US$ Million Figure 10: U.S Thyroid Cancer Hormone Replacement Market: 2010-2014-US$ Million Figure 11: U.S Thyroid Cancer Hormone Replacement Market: 2015-2019-US$ Million Figure 12: Incidence of Thyroid Cancer Types: 2013 Figure 13: Percent of Cases by Stage of Cancer (US Patients, 2010-2013) Figure 14: U.S Thyroid Cancer Diagnosis Market- FNA Volume: 2010-2014 Figure 15: Cancer Type Result From FNA in Percentage Figure 136 U.S Thyroid Cancer Diagnosis Market- FNA Volume: 2015-2019 Figure 17: Increasing Thyroid Cancer Incidence: 2009-2013 Figure 18: Increasing Incidence in Middle Age Population Figure 19: U.S Middle Age population-2010-2014 Figure 20: The US Healthcare Expenditure Per Capita (2006-2013) Figure 21: U.S GDP Per capita- U.S$: 2010-2013 Figure 22: 5- Year Relative Survival Rate According To Thyroid Cancer Stage Figure 23: new cases and fatalities in women and men with thyroid cancer: 2013 Figure 24: Veracyte’s Revenue-U.S$ Million: 2011-2014 Figure 25: Veracyte’s Net Income (loss) -U.S$ Million: 2011-2014 Figure 26: Veracyte’s R$D Expenditure-U.S$ Million: 2011-2013
Figures & Tables: US Thyroid Cancer Market Figure 27: Oxigene Revenue-U.S$ Million: 2012-2013 Figure 28: Oxigene’s Net Income (loss) -U.S$ Million: 2011-2013 Figure 29: Forest Lab’s Revenue-U.S$ Billion: 2011-2013 Figure 30: Oxigene’s Net Income (loss) -U.S$ Million: 2011-2013 Figure 31: Mylan Inc. Revenue-U.S$ Billion: 2011-2013 Figure 32: Oxigene’s Net Income -U.S$ Billion: 2011-2013 Figure 33: Abbott Laboratories Revenue share by Business Unit (2013) Figure 34: Abbott Laboratories Revenue and Net Income (2009-2013)-US$ Billion Table 1: TNM Classification for Differentiated Thyroid Cancer Table 2: FDA Approved drugs for thyroid cancer treatment Table 3: Investigational agents for thyroid cancer Table 4: 5-Year and 10-Year Survival Rate by cancer type Table 5: U.S Major Players of Thyroid Cancer Market
Title: US Thyroid Cancer Market: Trends and Opportunities (2015-2019) Published: April 2015 Pages: 75 Price: US$ 800 (Single-User License) : US$ 1600 (Corporate License)
For placing an order of the Report, please press the following link:
http://www.daedal-research.com/us-thyroid-cancer-market-trends-and-opportunities-2015-2019
For more details please contact Mr. Rajeev Kumar: Tel: +91-120-4553017 (9.30 am - 6.30 pm) IST Mobile: +91-8743975789 (24 X7) Enquiries: info@daedal-research.com
Daedal Research
Daedal Research is a research and consulting firm specialized in providing research reports and customized business research and analysis. The research firm offers a blend of the best strategic consulting and market research solutions, which promise data rich, cost effective, and highly insightful analysis to help its clients with perfect answers to their important business queries .